Axe Compute is a small-cap company that recently pivoted from oncology drug discovery toward two linked businesses: GPU compute services and a cryptocurrency treasury strategy built around the Aethir network and its native token, ATH. On the compute side, Axe Compute sells on-demand GPU capacity to enterprises, AI developers, and high-performance computing operators, sourcing that capacity through Aethir's decentralized physical infrastructure network rather than owning data centers. Customers are provisioned within 48 hours and pay on a per-GPU per-hour basis under reserved-capacity contracts, typically 12–36 months. On the treasury side, Axe Compute holds ATH tokens on its balance sheet, earns staking yield, and purchases locked ATH at a discount to spot price. As of December 31, 2025, the company held approximately 6.35B ATH tokens with an aggregate market value of roughly $55M on an as-if-vested basis. The two businesses are linked: when Axe Compute purchases ATH to settle compute obligations, management claims to earn an additional 20% in ATH tokens, creating a compounding relationship between compute revenue and token holdings. Axe Compute also retains a legacy oncology drug discovery business — which uses AI and a biobank of 150,000+ tumor samples to help biopharma clients predict drug response — but is actively exploring selling or spinning it off. With only 14 employees, Axe Compute is a very small organization with its balance sheet heavily concentrated in a single, volatile digital asset.